Daniel Segna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniel Segna has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Annalisa Berzigotti
Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
3 shared publications André G. Uitterlinden
Department of Internal Medicine & Department of Epidemiology, Erasmus Medical Center Rotterdam, The Netherlands
1 shared publicationAnn Schwartz
Departments of Medicine and Epidemiology & Biostatistics, University of California, San Francisco, United States
1 shared publicationAnne R. Cappola
10University of Pennsylvania School of Medicine, Philadelphia, PA, United States
1 shared publicationApostolos Gogakos
13Department of Medicine, Imperial College London, London, United Kingdom
1 shared publicationBenjamin Messerli
Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
1 shared publication
Latest Publications
- Open Access
- 13 December 2025
- Published by Elsevier in JHEP Reports
- Vol. 8 (3) , 101712
Compression pressure of the external jugular vein for the assessment of intravascular volume status in decompensated cirrhosis: A pilot study
- 13 December 2025
- Published by Elsevier in JHEP Reports
- Vol. 8 (3) , 101712
Open AccessCompression pressure of the external jugular vein for the assessment of intravascular volume status in decompensated cirrhosis: A pilot study
- 17 October 2025
- Published by Springer Nature
- p. 109-119
Nichtinvasive Diagnostik der portalen Hypertension
- 17 October 2025
- Published by Springer Nature
- p. 109-119
Nichtinvasive Diagnostik der portalen Hypertension
- Open Access
- 20 August 2025
- Published by Elsevier in JHEP Reports
- Vol. 7 (11) , 101559
Point-of-care ultrasound of the inferior vena cava for intravascular volume assessment during intravenous albumin infusion in patients with cirrhosis
- 20 August 2025
- Published by Elsevier in JHEP Reports
- Vol. 7 (11) , 101559
Open AccessPoint-of-care ultrasound of the inferior vena cava for intravascular volume assessment during intravenous albumin infusion in patients with cirrhosis
- 16 October 2017
- Published by Wiley in Journal of Internal Medicine
- Vol. 283 (1) , 56-72
Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts
Background: Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.Objective: To investigate the association between subclinical thyroid dysfunction and bone loss.Methods: Individual participant data analysis was performed after a systematic literature search inMEDLINE/EMBASE(1946–2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid‐stimulating hormone [TSH] 0.45–4.49 mIU/L),SHyper (TSH< 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50–19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentageBMDchange (%ΔBMD) from serial dual X‐ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random‐effects two‐step approach.Results: Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) hadSHypo and 284 (5.2%) hadSHyper. During 36 569 person‐years of follow‐up, those withSHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD= −0.18 (95% CI: −0.34, −0.02;I2= 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = −0.14 (95% CI: −0.38, 0.10;I2= 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: −0.30, 0.36;I2= 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = −0.59; [95% CI: −0.99, −0.19]) and total hip region (%ΔBMD = −0.46 [95% CI: −1.05, −0.13]). In contrast,SHypo was not associated with bone loss at any site.Conclusion: Amongst adults,SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.
- 16 October 2017
- Published by Wiley in Journal of Internal Medicine
- Vol. 283 (1) , 56-72
Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts
Background: Subclinical hyperthyroidism (SHyper) has been associated with increased risk of hip and other fractures, but the linking mechanisms remain unclear.Objective: To investigate the association between subclinical thyroid dysfunction and bone loss.Methods: Individual participant data analysis was performed after a systematic literature search inMEDLINE/EMBASE(1946–2016). Two reviewers independently screened and selected prospective cohorts providing baseline thyroid status and serial bone mineral density (BMD) measurements. We classified thyroid status as euthyroidism (thyroid‐stimulating hormone [TSH] 0.45–4.49 mIU/L),SHyper (TSH< 0.45 mIU/L) and subclinical hypothyroidism (SHypo, TSH ≥ 4.50–19.99 mIU/L) both with normal free thyroxine levels. Our primary outcome was annualized percentageBMDchange (%ΔBMD) from serial dual X‐ray absorptiometry scans of the femoral neck, total hip and lumbar spine, obtained from multivariable regression in a random‐effects two‐step approach.Results: Amongst 5458 individuals (median age 72 years, 49.1% women) from six prospective cohorts, 451 (8.3%) hadSHypo and 284 (5.2%) hadSHyper. During 36 569 person‐years of follow‐up, those withSHyper had a greater annual bone loss at the femoral neck versus euthyroidism: %ΔBMD= −0.18 (95% CI: −0.34, −0.02;I2= 0%), with a nonstatistically significant pattern at the total hip: %ΔBMD = −0.14 (95% CI: −0.38, 0.10;I2= 53%), but not at the lumbar spine: %ΔBMD = 0.03 (95% CI: −0.30, 0.36;I2= 25%); especially participants with TSH < 0.10 mIU/L showed an increased bone loss in the femoral neck (%Δ BMD = −0.59; [95% CI: −0.99, −0.19]) and total hip region (%ΔBMD = −0.46 [95% CI: −1.05, −0.13]). In contrast,SHypo was not associated with bone loss at any site.Conclusion: Amongst adults,SHyper was associated with increased femoral neck bone loss, potentially contributing to the increased fracture risk.